Immune cell trafficking and activity are implicated in the parturition process, but little is known about the role of macrophages in control of uterine contractility at term. In the present study, we tested the hypothesis that endotoxin (lipopolysaccharide [LPS]) enhances uterine contractile activity through a mechanism that involves activation of resident macrophages. Various uterotonins and anti-inflammatory mediators were added to a standard muscle bath preparation that contained strips of uterus from Day 15 pregnant C3H/HeN mice. Spontaneous and agonist-induced contractile activity was enhanced following LPS treatment. LPS increased amplitude but not frequency of contractions. Addition of anti-inflammatory cytokines, interleukin 10 or transforming growth factor ␤, to suppress macrophage activation did not block LPS-induced increases in contractility. By contrast, indomethacin given to block prostaglandin production suppressed the LPS-induced increase in amplitude of contractions. These findings suggest that an inflammatory response, possibly mediated by activation of macrophages and prostaglandins, participates in the regulation of amplitude but not frequency of contractile activity by the murine uterus before onset of parturition.
INTRODUCTION
Enhanced immune cell activity is implicated in the etiology of a majority of cases of premature labor in humans [1, 2] . In pregnant mice, induction of an inflammatory immune response initiates labor [3] [4] [5] [6] [7] [8] . Premature delivery can be induced within 24 h, 3-4 days before term, by systemic administration of the endotoxin lipopolysaccharide (LPS). Although LPS can induce both systemic and central reactions [9] [10] [11] [12] , the early termination of pregnancy may result from enhanced local production of uterotonins and inflammatory cytokines from the predominant immune cell, the macrophage, which resides in endometrial stroma and around myometrial bundles in the uterus [13] [14] [15] . Indeed, timing of various LPS treatments that cause preterm delivery occur when numbers of resident macrophages and ac- tivated macrophages are increased several fold compared with that in the nongravid or peripartum uterus [13, 14, 16] .
Macrophages are a major component of inflammatory immune responses to LPS [17] . Activation of immune cells, a most likely consequence of LPS binding to toll-like receptor 4 (TLR-4), produces an inflammatory reaction [18] [19] [20] . As part of this cascade, increased production by activated macrophages of interleukin (IL) 1 and prostaglandins occurs; these factors are known to enhance uterine contractile activity [21, 22] . IL-1 mimics the effect of LPS in inducing preterm labor [7] , but initiation of labor by IL-1 may be counteracted by transforming growth factor ␤ (TGF␤) [23] . TGF␤ is an anti-inflammatory cytokine that along with IL-10 (a negative feedback product of macrophages) inhibits the activation of macrophages [24] . These cytokines may facilitate quiescence of the pregnant uterus before term and counter the influence of uterotonins to promote contractility. As part of the final common mechanism for initiation of labor, prostaglandins are essential for the process of parturition [25, 26] , and LPS-induced preterm labor in mice is dependent upon prostaglandin production [27] . This evidence suggests that a local inflammatory cytokine response and actions by prostaglandins may contribute to LPS-mediated preterm birth.
Whether LPS or macrophage products directly regulate contractile activity by the pregnant uterus has yet to be determined. In mice, administration of LPS or inflammatory cytokines did not acutely alter spontaneous contractile activity [28] . However, in vitro treatment with IL-1␤ potentiated oxytocin (OT)-induced myometrial contractility in the rat [29] . In these studies, the decidua was specifically removed before treatment; damage to cellular constituents in the intervening stromal regions and elimination of significant numbers of resident macrophages in endometrium could have reduced the concentrations of uterotonins or blocked paracrine interactions. These considerations may be essential for increased amplitude of uterine contractility and enhanced responsiveness to OT that occur before onset of parturition [30] . To assess the role of resident macrophages on spontaneous and agonist-induced contractility, the present study tested the hypothesis that inflammatory mediators regulate contractile activity by the intact gravid murine uterus near term. .67-min period during baseline periods (events 1 and 3) and after OT challenge (events 2 and 10). Contractile activity was recorded immediately after administration of the anti-inflammatory reagents (event 4) IL-10 and TGF␤ or the administration of Indo. Recordings were made after LPS was added to the incubation chamber and at hourly intervals over the next 4 h (events 5-9). K ϩ challenge at the conclusion of the study confirmed viability of each strip of uterine tissue. Time line is set to visualize experimental protocol chronology rather than actual time scale.
MATERIALS AND METHODS

Animals
mice, the uterus is characteristically in a quiescent phase of contractile activity, treatment with endotoxin induces preterm birth, and macrophages are more numerous than at other times of pregnancy [3, 14, 30] . The research protocol was reviewed and approved by the Institutional Animal Care and Use Committee.
Uterine Contractile Activity
Uterine contractile activity was assessed as previously described [30, 31] . Strips (2 ϫ 5 mm) were cut from the middle regions of each uterine horn. Care was taken to insure that the endometrium remained intact on the myometrial strips. Ten uterine strips were obtained from each gravid uterus. Each strip was longitudinally mounted on a calibrated isometric transducer in a standard muscle bath preparation that contained 5 ml of oxygenated Na ϩ -Krebs buffer at pH 7.4 and 37ЊC. Tissues were prepared during the first hour and equilibrated to approximately 1 g tension for the initial baseline recording. The time course of uterine contractile activity before and after treatment was assessed over a 4-h period (Fig. 1 ). An event consisted of 200 records, each a recording of current grams of tension every 2 sec over a 6.67-min period beginning at the time of specified treatment. The contractile response to OT (Bachem, Torrance, CA) was assessed after a 10 Ϫ8.8 M dose of OT was added to each incubation chamber (EC 50 dose [30] ). After exposure to OT, tissue was washed and reequilibrated for 10 min in Na ϩ -Krebs buffer. Duplicate strips of tissue were then treated with an anti-inflammatory cytokine, either IL-10 (10 ng/ml; Endogen, Woburn, MA), which is an inhibitor of macrophage activation, inflammatory cytokine production, and prostaglandin (PG) E 2 production [32] [33] [34] , or TGF␤ (10 ng/ml; R&D Systems, Minneapolis, MN), which is known to block IL-1␤-induced preterm delivery in mice [23] . To inhibit endogenous PG biosynthesis, a third set of uterine strips was treated with indomethacin (Indo, 10 Ϫ5 M; Sigma, St. Louis, MO) [35, 36] . Doses were chosen based on published efficacy of treatments. After 7 min, LPS (10 g/ml; Sigma) was added to the incubation solution. Thus, group designations are IL-10 ϩ LPS, TGF␤ ϩ LPS, and Indo ϩ LPS, respectively. As a positive control, uterine strips that were initially treated with saline were given LPS, and a group given only incubation medium during the entire study served as a no-treatment negative control (Con). Contractile activity was recorded after addition of cytokines, Indo, or LPS and thereafter at hourly intervals. About 4 h after the onset of treatment, uterine strips were again challenged with OT. At the conclusion of the study, tissue was treated with 120 mM/L K ϩ to stimulate a maximal contractile response and confirm viability.
Data Analysis and Statistics
Contractile activity by each longitudinal uterine strip was analyzed in three ways. Total contractile force generated, i.e., integrated area, and frequency and amplitude of contractions were determined as previously described [30] . Automated mesurements were made with AcqKnowledge Software 3.5.7 (Biopac Systems, Santa Barbara, CA). A sensitivity threshold setting of 75% exceeded 95% coincidence compared with a randomized manual analysis of raw data. The area, amplitude, and frequency of contractile activity by duplicate uterine strips were averaged with respect to treatment period. Data were evaluated by one-way ANOVA (SPSS, Chicago, IL); outliers were excluded based upon stem and leaf analysis. When main effects were significant, individual comparisons were made using the least significant difference test (time course versus treatment) or Student t-test (OT challenge versus baseline effects). Differences were considered significant at P Ͻ 0.05. If the results of the Levene test for homogeneity of variance were significant, data were log transformed and reanalyzed. In a few instances, data were not normally distributed, in which case the nonparametric Kruskal-Wallis test with multiple comparisons was used.
RESULTS
Regular and repetitive contractions were demonstrated by every uterine strip throughout the study period (Fig. 1) . Contractile activity of untreated uterine strips (i.e., only buffer solution in the bath) was unchanged throughout the baseline periods. Area, amplitude, and frequency of contractions were not significantly different over the 5-h study period (events 1, 3-9; ANOVA: P Ͼ 0.1, df ϭ 7; data not shown).
Effects of LPS on Contractile Activity: Influence of Treatment with Cytokines or Indo
Treatment with LPS influenced some but not all aspects of uterine contractile activity. Following administration of LPS, neither frequency nor area of contractions was significantly different than those measures obtained during baseline periods ( Fig. 2 ; data for area not shown). However, amplitude of contractions increased by 2 h after LPS treatment, an effect that was sustained for the duration of the study (events 1, 3, and 4 reduced compared with events 7-9; ANOVA: P Ͻ 0.002, df ϭ 7).
Administration of anti-inflammatory cytokines did not block the ability of LPS to increase contractile activity. IL-10 or TGF␤ treatment alone did not influence any parameter of contractile activity (P Ͼ 0.05 for events 1 and 3 versus 4; Fig. 2 , middle panels). For both cytokine treatment groups, as with the LPS group, neither area nor frequency of contractions demonstrated sustained differences compared with those values during baseline periods. However, amplitude of contractions after addition of LPS to uterine strips rose earlier in strips incubation with IL-10 or TGF␤ (P Ͻ 0.03, events 4 versus 7-9 for IL-10 or 6-9 for TGF␤ groups). Thus, the rise in contraction amplitude in the IL-10 or TGF␤ given LPS occurred 2 h and 1 h earlier, respectively, than it did in those uterine strips treated with LPS alone.
Indo did not alter baseline contractile activity, but it blocked the effects of LPS. A regular episodic waveform of contractions persisted over the 5-h study period. The area, amplitude, and frequency of contractions did not vary with respect to treatment with Indo or LPS (ANOVA: P Ͼ 0.1, df ϭ 7).
Oxytocin Effects on Contractile Activity: Baseline and Treatment Responses
In controls, i.e., untreated tissue, OT treatments enhanced area (total integrated force), amplitude, and fre- Contractile activity during baseline events (1 and 3) served as controls to assess effects of administration just before event 4 (᭞) of treatment with cytokine (IL-10, 10 ng/ml; TGF␤, 10 ng/ml) or Indo (10 Ϫ5 M). LPS (᭢, 10 g/ml) was added immediately before event 5, and measurements were recorded at hourly intervals thereafter. Contractility by untreated uterine strips was unchanged throughout the entire study period (data not shown). Letters indicate a significant difference (P Ͻ 0.05) compared with event 1 (a), events 1 and 3-5 (b), or events 1, 3, 4, and 9 (c) of the same treatment group.
FIG. 3.
Effect of OT on in vitro contractile activity of uterine strips from mice on Day 15 of pregnancy. Data are the mean (ϮSEM, duplicate strips for 5-7 mice) integrated area, amplitude, and frequency of contractions during a 6.67-min recording period at specified events. Left: Recordings for the initial baseline period (event 1) served as controls for those recordings made immediately after OT max was added to the incubation chamber for events 2 or 10. Right: Contractile activity after administration of LPS to uterine strips treated with medium, IL-10, TGF␤, or Indo as described in Figure 1 (event 10 ). Letters indicate a significant difference (P Ͻ 0.05) for comparisons with event 1 (a), or events 1 and 2 in Control group (b), or event 10 and all other LPS treatment groups (*).
quency of contractions relative to that during the initial baseline period. Comparison of events 1 and 2 (Fig. 3, left) indicated that OT induced a 2.1%, 1.58%, and 2.65% increase in contraction area, amplitude, and frequency, respectively, compared with baseline values (P Ͻ 0.0001, t ϭ Ϫ4.75 to Ϫ12.0, df ϭ 52-54). Replication of the OT challenge (event 10) produced a response similar to that in event 2 for area and frequency of contractions. However, a further increase in contraction amplitude of 38% between the initial and second OT treatment was evident (P Ͻ 0.005, t ϭ Ϫ3.033, df ϭ 30).
LPS treatment did not affect the contractile response to OT by uterine strips (Fig. 3, right) . Administration of OT increased area, amplitude, and frequency of contractions in tissue incubated for 4 h with LPS alone, an increase comparable to the OT response in untreated controls (event 10 versus 2, same treatment group; P Ͼ 0.06, t Ͻ Ϫ2, df ϭ 12). Administration of LPS did not alter responsiveness to OT. Prior treatment with anti-inflammatory cytokines IL-10 or TGF␤ did not interfere with increased contractile activity induced by OT. By contrast, contraction amplitude in response to OT was significantly suppressed in tissue treated with Indo despite the presence of LPS for more than 3 h. Neither area nor frequency of contractions following OT challenge was suppressed by Indo treatment.
DISCUSSION
Enhanced amplitude of spontaneous uterine contractile activity following treatment with endotoxin suggests that an inflammatory promoter can facilitate spontaneous contractile activity by the pregnant murine uterus. As previously reported, few or no effects of LPS were apparent for area, i.e., integrated force, or frequency of contractions [28] . Endotoxin potentiated contractile amplitude by 2 h after treatment, and the increased amplitute was sustained for the 4-h study period (events 7-9). Focus on effects of endotoxin on amplitude rather than on frequency of contraction raises the possibility that endotoxin may act to synchronize myometrial activity rather than drive an endogenous pacemaker that initiates each contraction waveform. This effect parallels evidence that enhanced amplitude of myometrial contractions precedes onset of labor in mice [30] . Therefore, local coordination of powerful contractions rather than changes in frequency may be a common prerequisite for enhanced uterine contractility at term and in preterm labor.
LPS-enhanced amplitude of uterine contractions may underlie the ability of endotoxin, gram-negative infection, or related cytokines to induce premature labor and delivery in mice [3] and possibly in women [37, 38] . Preterm birth in women is, in a majority of cases, associated with microbial invasion of the chorion, amnion, endometrium, or placenta, with inflammatory cytokines in the amniotic fluid, or with premature rupture of fetal membranes [7, [39] [40] [41] [42] . Resident phagocytes are the principal if not the only cell type in the female reproductive tract with a receptor-mediated signal transduction mechanism that is essential for immune responses to LPS [18, 43] . LPS is a membrane component of gram-negative bacteria that binds to TLR-4, a potent activator of monocytic phagocytes and macrophages [20, 44, 45] . Moreover, macrophages are a local source for PG production in the murine uterus [46] and are present in high numbers on Day 15 of pregnancy relative to their abundance in the peripartum period or in virgin mice [14, 18] . In the present study, the sustained increase in amplitude of spontaneous contractions following LPS treatment was likely related to a cascade of effects that results from enhanced local production of PGs within uterine strips [2] . This hypothesis is supported by the ability of Indo, an inhibitor of PG synthesis, to block LPS-induced increases in contraction amplitude.
To counter stimulation of contractile activity by LPS, uterine strips were treated with an anti-inflammatory cytokine to suppress macrophage activation. IL-10 and TGF␤ were used because these cytokines are endogenous inhibitors of other inflammatory cytokines and of PG production [33] and are implicated in processes of parturition [23, 47] . However, neither IL-10 nor TGF␤ treatment influenced baseline uterine contractile activity (event 4 versus event 3; Fig. 2 ) or blocked the ability of LPS to increase the amplitude of spontaneous contractions. The lack of effect of such anti-inflammatory treatments on LPS-induced contractile activity may reflect an influence of endotoxin that overrides amelioration by anti-inflammatory cytokines. Responsiveness by resident macrophages to cytokines may also depend upon dose, duration, or timing of anti-inflammatory treatments. In addition, absence of anti-inflammatory efficacy may reflect a paradoxical priming of leukocytes; in certain instances, IL-10 actually enhances the capacity of mononuclear phagocytes to produce inflammatory cytokines [48] . Amplitude of contractions in uterine strips treated with TGF␤ and LPS increased 1 h earlier than did those in tissue treated with LPS alone (event 6 versus event 7; Fig. 2 ). These considerations do not exclude the possibility that an appropriate anti-inflammatory treatment may block the influence of endotoxin on uterine contractility at this stage of pregnancy.
More macrophages are present in the murine uterus on Day 15 of pregnancy than in peripartum or nonpregnant mice, and a major proportion of these macrophages is already activated, i.e., express the intercellular adhesion molecule activation marker CD54 [14, 16] . Increased inducible nitric oxide synthase (iNOS) activity by resident macrophages may contribute to nitric oxide production and restrain uterine contractility [13, 49] . Suppressed myometrial contractility is associated with increased iNOS and high nitric oxide production in the uterus during pregnancy [50] [51] [52] . Overcoming this restraint may be related to local production of PGs. Macrophages have been suggested as an important source of PGs for uterine activity [21] . As potent agonists that promote contractile activity by the uterus, PGs or precursor treatments can initiate preterm labor throughout gestation. PGs stimulate phasic myometrial contractions by intracellular signaling pathways involving activation of phosphatidylinositol and the production of cytosolic calcium oscillations [53] . Thus, enhanced contractile activity following LPS-induced immune activation could be a consequence of increased cytokine and PG, along with decreased iNOS production. As recently reviewed by Romero et al. [54] , functional genomic and proteomic studies have also implicated inflammatory processes in term and preterm parturition. The list of genes implicated includes IL-8, integrin ␣v , cytokine receptor EB13, and vascular endothelial growth factor receptor 1. Therefore, diverse evidence has implicated an immunological component to activation of processes in the pregnant uterus during premature labor and the initial phase of parturition.
The results of this study suggest that a local immune response to endotoxin activates increases in the amplitude of uterine contractions. Endotoxin did not interfere with the uterotonic effects of OT. As the principal cell population capable of responding to endotoxin in the pregnant murine uterus, macrophages may contribute to endotoxin-induced preterm labor. Attempts to preempt effects of LPS with IL-10 and TGF␤ were ineffective for a variety of reasons, but these findings do not exclude the possibility that resident macrophages may participate in the process through which endotoxin directly affects uterine contractility. More generally, increased uterine contractility appears to represent a local shift in uterine leukocyte activities that facilitate quiescence to stimulatory influences that promote synchronous and powerful contractions. These findings implicate an influence of immune cell activities in infection-related processes that may advance parturition.
